Stem cells, immunotherapy, and antibodies are the new beginning in cancer treatments.
Experts discuss the process and review the future of different forms of treatment and the cost associated with them.
During the final quarter of the Stanford Mini Med School, some of the most timely and important topics in contemporary medicine and the biosciences are addressed.
Stanford Mini Med School is a series arranged and directed by Stanford’s School of Medicine and presented by the Stanford Continuing Studies program.
Philip Beachy, Ph.D., and Ron Levy, Ph.D. discuss different approaches to cancer therapy, research, and clinical trials, such as drug, antibody, and stem cell therapies.
Advance Video to Dr. Ron Levy, Ph.D. Discussion on his trial examples